NFX1-123在HPV阳性头颈鳞癌中高表达
研究利用癌症基因组图谱剪接变异数据库和头颈鳞癌细胞系,量化NFX1-123及其在宫颈癌中升高的相关基因在HPV阳性与阴性头颈鳞癌中的表达。结果显示NFX1-123在HPV阳性头颈鳞癌中高于HPV阴性者,LCE1B、KRT16、SPRR2G和FBN2在头颈鳞癌中高表达,Notch1和CCNB1IP1在HPV阳性者中表达更高。
要点
- NFX1-123在HPV阳性头颈鳞癌中表达高于HPV阴性者。
- LCE1B、KRT16、SPRR2G、FBN2在头颈鳞癌中较正常组织高表达。
- Notch1和CCNB1IP1在HPV阳性头颈鳞癌中表达高于HPV阴性者。
核心结论
- NFX1-123及其部分已知靶基因在HPV阳性头颈鳞癌中表达升高。
研究设计与样本
- 使用癌症基因组图谱剪接变异数据库和头颈鳞癌细胞系量化NFX1-123及相关细胞基因表达。
主要发现
- NFX1-123在HPV阳性头颈鳞癌中较HPV阴性头颈鳞癌增加。
- LCE1B、KRT16、SPRR2G和FBN2在头颈鳞癌中较正常组织高表达。
- Notch1和CCNB1IP1在HPV阳性头颈鳞癌中较HPV阴性头颈鳞癌表达更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-risk human papillomaviruses (HR HPV) cause nearly all cervical cancers and, in the United States, the majority of head and neck cancers (HNSCCs). NFX1-123 is overexpressed in cervical cancers, and NFX1-123 partners with the HR HPV type 16 E6 oncoprotein to affect multiple growth, differentiation, and immune response genes. However, neither the expression of NFX1-123 nor the levels of these genes have been investigated in HPV positive (HPV+) or negative (HPV-) HNSCCs. METHODS: The Cancer Genome Atlas Splicing Variants Database and HNSCC cell lines were used to quantify expression of NFX1-123 and cellular genes increased in cervical cancers. RESULTS: NFX1-123 was increased in HPV+ HNSCCs compared to HPV- HNSCCs. LCE1B, KRT16, SPRR2G, and FBN2 were highly expressed in HNSCCs compared to normal tissues. Notch1 and CCNB1IP1 had greater expression in HPV+ HNSCCs compared to HPV- HNSCCs. CONCLUSION: NFX1-123 and a subset of its known targets were increased in HPV+ HNSCCs.
引用
- Chintala S, Quist KM, Gonzalez-DeWhitt PA, et al. High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas. Head Neck. 2021. PMID: 34693597. doi:10.1002/hed.26906
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。